Abstract
Background
This meta-analysis aimed to determine the role of human fatty acid binding protein 2 (FABP2) expression in the diagnosis of necrotizing enterocolitis (NEC) of newborns.
Data sources
Eligible studies for further statistical analysis were identified from various databases including PubMed, Expert Medica Database, Web of Science, Cochrane Library, Google Scholar, China BioMedicine and China National Knowledge Infrastructure. Random effects model was used, and summary standardized mean difference (SMD) with its 95% confidence interval (CI) was calculated to assess the association of FABP2 expression and NEC.
Results
Ten articles which included 572 infants (262 infants with NEC and 310 healthy controls) were included in the current meta-analysis. FABP2 showed a positive relationship with NEC of newborns (SMD=2.88, 95% CI=2.09-3.67, P<0.001). And FABP2 expression was higher in patients with advanced stage of NEC (stage III or stage II+III) than in those with early stage of NEC (stage I) (SMD=-0.48, 95% CI=-0.87 to -0.09, P=0.015). Ethnicity-stratified analysis yielded significantly different estimates with a high FABP2 expression in NEC in both Caucasians (SMD=3.16, 95% CI=1.90-4.43, P<0.001) and Asians (SMD=2.57, 95% CI=1.50-3.64, P<0.001). Sample-based subgroup analysis showed that FABP2 expression was positively correlated with neonatal NEC in both urinary- and blood-sample subgroups (all P<0.05).
Conclusion
The results prove that the high FABP2 expression is related to the damage to intestinal cells, which may be a possible early detection marker identifying neonatal NEC.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Panigrahi P. Necrotizing enterocolitis: a practical guide to its prevention and management. Paediatr Drugs 2006;8:151–165.
Josefsson S, Bunn SK, Domellöf M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr 2007;44:407–413.
Björkström MV, Hall L, Söderlund S, Håkansson EG, Håkansson S, Domellöf M. Intestinal flora in very low-birth weight infants. Acta Paediatr 2009;98:1762–1767.
Däbritz J, Jenke A, Wirth S, Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr 2012;161:1059–1064.
Okogbule-Wonodi AC, Gross GW, Sun CC, Agthe AG, Xiao L, Waites KB, et al. Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res 2011;69:442–447.
Terrin G, Passariello A, De Curtis M, Paludetto R, Berni Canani R. S100 A8/A9 protein as a marker for early diagnosis of necrotising enterocolitis in neonates. Arch Dis Child 2012;97:1102.
Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, et al. Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis. J Pediatr 2014;164:1486–1488.
Afrazi A, Sodhi CP, Richardson W, Neal M, Good M, Siggers R, et al. New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr Res 2011;69:183–188.
Reisinger KW, Elst M, Derikx JP, Nikkels PG, De Vries B, Adriaanse MP, et al. Intestinal fatty acid-binding protein: a possible marker for gut maturation. Pediatr Res 2014;76:261–268.
Schurink M, Scholten IG, Kooi EM, Hulzebos CV, Kox RG, Groen H, et al. Intestinal fatty acid-binding protein in neonates with imminent necrotizing enterocolitis. Neonatology 2014;106:49–54.
Briana DD, Liosi S, Gourgiotis D, Boutsikou M, Baka S, Marmarinos A, et al. Cord blood intestinal fatty acid-binding protein (I-FABP) in full-term intrauterine growth restricted pregnancies. J Matern Fetal Neonatal Med 2012;25:2062–2065.
Aydemir C, Dilli D, Oguz SS, Ulu HO, Uras N, Erdeve O, et al. Serum intestinal fatty acid binding protein level for early diagnosis and prediction of severity of necrotizing enterocolitis. Early Hum Dev 2011;87:659–661.
Evennett NJ, Hall NJ, Pierro A, Eaton S. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010;45:735–740.
Rowland A, Knights KM, Mackenzie PI, Miners JO. Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters. Drug Metab Dispos 2009;37:1395–1403.
Reisinger KW, Derikx JP, Thuijls G, van der Zee DC, Brouwers HA, Van Bijnen AA, et al. Noninvasive measurement of intestinal epithelial damage at time of refeeding can predict clinical outcome after necrotizing enterocolitis. Pediatr Res 2013;73:209–213.
Thuijls G, Derikx JP, Van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL, et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010;251:1174–1180.
Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept 2008;147:25–28.
Derikx JP, Vreugdenhil AC, Van den Neucker AM, Grootjans J, Van Bijnen AA, Damoiseaux JG, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009;43:727–733.
Ng EW, Poon TC, Lam HS, Cheung HM, Ma TP, Chan KY, et al. Gut-associated biomarkers L-FABP, I-FABP, and TFF3 and LIT score for diagnosis of surgical necrotizing enterocolitis in preterm infants. Ann Surg 2013;258:1111–1118.
Reisinger KW, van der Zee DC, Brouwers HA, Kramer BW, Van Heurn LW, Buurman WA, et al. Noninvasive measurement of fecal calprotectin and serum amyloid A combined with intestinal fatty acid-binding protein in necrotizing enterocolitis. J Pediatr Surg 2012;47:1640–1645.
Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 2012;31:3805–3820.
Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in metaanalysis. JAMA 2006;295:676–680.
Zintzaras E, Ioannidis JP. HEGESMA: genome search metaanalysis and heterogeneity testing. Bioinformatics 2005;21:3672–3673.
Qin JL, Wei H, Li LQ, Wang Y. The value of serum intestinal fatty acid binding protein in the diagnosis of necrotizing enterocolitis. Chin J Pediatr Surg 2013;34:590–594. [In Chinese]
Li C, Ren XY, Cai WX, Niu FH. Cytokines and intestinal fatty acid binding protein for early diagnosis and determination of the severity of necrotizing enterocolitis. Shandong Medical J 2013;53:50–51. [In Chinese]
Derikx JP, Evennett NJ, Degraeuwe PL, Mulder TL, Van Bijnen AA, Van Heurn LW, et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 2007;56:1473–1475.
Guthmann F, Börchers T, Wolfrum C, Wustrack T, Bartholomäus S, Spener F. Plasma concentration of intestinal-and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002;239:227–234.
Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002;22:5114–5127.
Evennett N, Alexander N, Petrov M, Pierro A, Eaton S. A systematic review of serologic tests in the diagnosis of necrotizing enterocolitis. J Pediatr Surg 2009;44:2192–2201.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Jiang, LF., Zhang, RP. et al. Clinical significance of FABP2 expression in newborns with necrotizing enterocolitis. World J Pediatr 12, 159–165 (2016). https://doi.org/10.1007/s12519-015-0035-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-015-0035-1